Publications

J. Fučíková, M. Podrazil, L. Jarolim, P. Bilková, M. Hensler, E. Becht, Z. Gasová, J. Kloucková, J. Kayserová, R. Horváth, A. Fialová, K. Vávrová, K. Sochorová, D. Rožková, R. Špíšek, J. Bartůňková

Phase I/II trial of dendritic cell-based active cellular immunotherapy with DCVAC/PCa in patients with rising PSA after primary prostatectomy or salvage radiotherapy for the treatment of prostate cancer.

Cancer Immunol Immunother. 2018 Jan;67(1):89-100.

C. Vanpouille-Box, C. Lhuillier, L. Bezu, F. Aranda, T. Yamazaki, O. Kepp, J. Fucikova, R. Spisek, S. Demaria, S.C. Formenti, L. Zitvogel, G. Kroemer, L. Galluzzi

Trial watch: Immune checkpoint blockers for cancer therapy.

Oncoimmunology. 2017 Aug 31;6(11):e1373237. doi: 10.1080/2162402X.2017.1373237. eCollection 2017.

R. Mikyskova, M. Indrova, I. Stepanek, I. Kanchev, J. Bieblova, S. Vosahlikova, I. Moserova, I. Truxova, J. Fucikova, J. Bartunkova, R. Spisek, R. Sedlacek, M. Reinis

Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure inhibit prostate tumor growth in TRAMP mice

Oncoimmunology. 2017 Aug 24;6(12):e1362528. doi: 10.1080/2162402X.2017.1362528. eCollection 2017.